EVOK

Evoke Pharma Inc

Insider trading activity for Evoke Pharma Inc, straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 6 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 12 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Transaction history

The 37 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Dec 17, 2025	Pyszczymuka Greg	Director	DTOISS◆	1,155	—	—	—	Open the original filing on SEC.gov
Dec 17, 2025	Pyszczymuka Greg	Director	DTOISS◆	5,833	—	—	—	Open the original filing on SEC.gov
Dec 17, 2025	Smeal Benjamin C.	Director	DTOISS◆	1,125	—	—	—	Open the original filing on SEC.gov
Dec 17, 2025	Smeal Benjamin C.	Director	DTOISS◆	5,833	—	—	—	Open the original filing on SEC.gov
Dec 17, 2025	Garner Cam L	Director	DTOISS◆	1,291	—	—	—	Open the original filing on SEC.gov
Dec 17, 2025	Garner Cam L	Director	DTOISS◆	8,750	—	—	—	Open the original filing on SEC.gov
Dec 17, 2025	Garner Cam L	Director	DTOISS◆	1,479	—	—	—	Open the original filing on SEC.gov
Dec 17, 2025	Hill Malcolm R	Director	DTOISS◆	1,218	—	—	—	Open the original filing on SEC.gov
Dec 17, 2025	Hill Malcolm R	Director	DTOISS◆	5,833	—	—	—	Open the original filing on SEC.gov
Dec 17, 2025	Hill Malcolm R	Director	DTOISS◆	1,218	—	—	—	Open the original filing on SEC.gov
Dec 17, 2025	Widder Kenneth J	Director	DTOISS◆	1,187	—	—	—	Open the original filing on SEC.gov
Dec 17, 2025	Widder Kenneth J	Director	DTOISS◆	5,833	—	—	—	Open the original filing on SEC.gov
Dec 17, 2025	Widder Kenneth J	Director	DTOISS◆	1,187	—	—	—	Open the original filing on SEC.gov
Dec 17, 2025	Kowieski Mark	Chief Financial Officer	DTOISS◆	13,000	—	—	—	Open the original filing on SEC.gov
Dec 17, 2025	Kowieski Mark	Chief Financial Officer	DTOISS◆	17,291	—	—	—	Open the original filing on SEC.gov
Dec 17, 2025	Reed Vickie S	Director	DTOISS◆	1,250	—	—	—	Open the original filing on SEC.gov
Dec 17, 2025	Reed Vickie S	Director	DTOISS◆	5,833	—	—	—	Open the original filing on SEC.gov
Dec 17, 2025	Reed Vickie S	Director	DTOISS◆	1,250	—	—	—	Open the original filing on SEC.gov
Dec 17, 2025	D'Onofrio Matthew J	Chief Executive Officer	DTOISS◆	70,000	—	—	—	Open the original filing on SEC.gov
Dec 17, 2025	D'Onofrio Matthew J	Chief Executive Officer	DTOISS◆	64,840	—	—	—	Open the original filing on SEC.gov
Dec 17, 2025	Carlson Marilyn R.	Chief Medical Officer	DTOISS◆	11,000	—	—	—	Open the original filing on SEC.gov
Dec 17, 2025	Carlson Marilyn R.	Chief Medical Officer	DTOISS◆	17,291	—	—	—	Open the original filing on SEC.gov
Dec 17, 2025	Brady Todd C	Director	DTOISS◆	1,187	—	—	—	Open the original filing on SEC.gov
Dec 17, 2025	Brady Todd C	Director	DTOISS◆	5,833	—	—	—	Open the original filing on SEC.gov
Dec 17, 2025	Brady Todd C	Director	DTOISS◆	1,218	—	—	—	Open the original filing on SEC.gov
Dec 17, 2025	Nantahala Capital…	10% Owner	JOTHER◆	250,627	$10.99	$2.8M	—	Open the original filing on SEC.gov
Dec 17, 2025	Nantahala Capital…	10% Owner	JOTHER◆	158,531	$10.99	$1.7M	—	Open the original filing on SEC.gov
Dec 17, 2025	Nantahala Capital…	10% Owner	JOTHER◆	117,019	$4.71	$551.2K	—	Open the original filing on SEC.gov
Dec 17, 2025	Nantahala Capital…	10% Owner	JOTHER◆	117,019	$4.71	$551.2K	—	Open the original filing on SEC.gov
Dec 17, 2025	Nantahala Capital…	10% Owner	JOTHER◆	433,962	$11.00	$4.8M	—	Open the original filing on SEC.gov
Dec 17, 2025	Nantahala Capital…	10% Owner	JOTHER	148,153	$11.00	$1.6M	-100.0%	Open the original filing on SEC.gov
Dec 16, 2025	Garner Cam L	Director	UTENDR	2,330	—	—	-100.0%	Open the original filing on SEC.gov
Dec 16, 2025	Hill Malcolm R	Director	UTENDR	133	—	—	-100.0%	Open the original filing on SEC.gov
Dec 16, 2025	Kowieski Mark	Chief Financial Officer	UTENDR	11,815	—	—	-100.0%	Open the original filing on SEC.gov
Dec 16, 2025	D'Onofrio Matthew J	Chief Executive Officer	UTENDR	15,509	—	—	-100.0%	Open the original filing on SEC.gov
Dec 16, 2025	Carlson Marilyn R.	Chief Medical Officer	UTENDR	360	—	—	-100.0%	Open the original filing on SEC.gov
Dec 16, 2025	Brady Todd C	Director	UTENDR	27	—	—	-100.0%	Open the original filing on SEC.gov

DTOISS◆—

Pyszczymuka Greg · DirectorDec 17, 2025

1,155 sh

DTOISS◆—

Pyszczymuka Greg · DirectorDec 17, 2025

5,833 sh

DTOISS◆—

Smeal Benjamin C. · DirectorDec 17, 2025

1,125 sh

DTOISS◆—

Smeal Benjamin C. · DirectorDec 17, 2025

5,833 sh

DTOISS◆—

Garner Cam L · DirectorDec 17, 2025

1,291 sh

DTOISS◆—

Garner Cam L · DirectorDec 17, 2025

8,750 sh

DTOISS◆—

Garner Cam L · DirectorDec 17, 2025

1,479 sh

DTOISS◆—

Hill Malcolm R · DirectorDec 17, 2025

1,218 sh

DTOISS◆—

Hill Malcolm R · DirectorDec 17, 2025

5,833 sh

DTOISS◆—

Hill Malcolm R · DirectorDec 17, 2025

1,218 sh

DTOISS◆—

Widder Kenneth J · DirectorDec 17, 2025

1,187 sh

DTOISS◆—

Widder Kenneth J · DirectorDec 17, 2025

5,833 sh

DTOISS◆—

Widder Kenneth J · DirectorDec 17, 2025

1,187 sh

DTOISS◆—

Kowieski Mark · Chief Financial…Dec 17, 2025

13,000 sh

DTOISS◆—

Kowieski Mark · Chief Financial…Dec 17, 2025

17,291 sh

DTOISS◆—

Reed Vickie S · DirectorDec 17, 2025

1,250 sh

DTOISS◆—

Reed Vickie S · DirectorDec 17, 2025

5,833 sh

DTOISS◆—

Reed Vickie S · DirectorDec 17, 2025

1,250 sh

DTOISS◆—

D'Onofrio Matthew J · Chief Executive…Dec 17, 2025

70,000 sh

DTOISS◆—

D'Onofrio Matthew J · Chief Executive…Dec 17, 2025

64,840 sh

DTOISS◆—

Carlson Marilyn R. · Chief Medical…Dec 17, 2025

11,000 sh

DTOISS◆—

Carlson Marilyn R. · Chief Medical…Dec 17, 2025

17,291 sh

DTOISS◆—

Brady Todd C · DirectorDec 17, 2025

1,187 sh

DTOISS◆—

Brady Todd C · DirectorDec 17, 2025

5,833 sh

DTOISS◆—

Brady Todd C · DirectorDec 17, 2025

1,218 sh

JOTHER◆$2.8M

Nantahala Capital… · 10% OwnerDec 17, 2025

250,627 sh @ $10.99

JOTHER◆$1.7M

Nantahala Capital… · 10% OwnerDec 17, 2025

158,531 sh @ $10.99

JOTHER◆$551.2K

Nantahala Capital… · 10% OwnerDec 17, 2025

117,019 sh @ $4.71

JOTHER◆$551.2K

Nantahala Capital… · 10% OwnerDec 17, 2025

117,019 sh @ $4.71

JOTHER◆$4.8M

Nantahala Capital… · 10% OwnerDec 17, 2025

433,962 sh @ $11.00

JOTHER$1.6M

Nantahala Capital… · 10% OwnerDec 17, 2025

148,153 sh @ $11.00 · -100.0% own

UTENDR—

Garner Cam L · DirectorDec 16, 2025

2,330 sh · -100.0% own

UTENDR—

Hill Malcolm R · DirectorDec 16, 2025

133 sh · -100.0% own

UTENDR—

Kowieski Mark · Chief Financial…Dec 16, 2025

11,815 sh · -100.0% own

UTENDR—

D'Onofrio Matthew J · Chief Executive…Dec 16, 2025

15,509 sh · -100.0% own

UTENDR—

Carlson Marilyn R. · Chief Medical…Dec 16, 2025

360 sh · -100.0% own

UTENDR—

Brady Todd C · DirectorDec 16, 2025

27 sh · -100.0% own

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

All 7 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.